Reese S. Terry

Develops and manufactures high-quality cardiovascular & endovascular medical devices

Engages in design, development, sale and marketing of implantable medical devices

Develops medical devices for endovascular uses

Functions as a College/University

Provides welfare services to people with epilepsy

MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks

Develops and markets complex devices for treating malfunctions of the heart

Develops non-invasive neuromodulation therapies